From Ruka, in Finland, to Turin, in Italy: September will be the month of the bioeconomy. The very first World BioEconomy Forum will be held in Ruka on 11-13 September. The Forum, born as an idea of Jukka Kantola, CEO of NC Partnering and KaiCell Fibers, will bring together professionals from the leading edge of the bioeconomy for face-to-face dialog in one of the world’s most beautiful areas of outstanding natural beauty. In Turin on 27-28 September will be held IFIB, the International Forum on Industrial Biotechnology and Bioeconomy.
French biotech company Global Bioenergies and German cars manufacturer Audi signed a new agreement focused on the implementation of residue usage, preparation of a path to commercialization and engine testing of new blends. Following the completion of a first series of engine testing and significant progresses of the isobutene bioproduction process, the two companies have agreed to start a new program.
LanzaTech, Virgin Atlantic and partners are one-step closer to building the world’s first large scale Alcohol to Jet (ATJ) facility producing commercial quantities of fuel in the UK. The commercial facility would convert low carbon ethanol produced from waste emissions, to jet fuel.
Royal DSM, the Dutch global science-based company in Nutrition, Health and Sustainable Living, is helping professional cyclists Team Sunweb to recover faster in this year’s Tour de France with its dietary antiplatelet, Fruitflow®. This forms part of the innovation partnership between DSM and Team Sunweb that aims to improve the health, nutrition and cycling materials of the professional athletes.
Amsterdam-based Avantium, a leading technology development company and forerunner in renewable chemistry, will officially open a pilot biorefinery for its Zambezi technology in Delfzijl, Netherlands. Opening ceremonies will take place in Amsterdam on 10 July and in Delfzijl on 13 July. The province of Groningen is supporting the pilot biorefinery with a RIG (‘Regionale Investeringssteun Groningen’) subsidy of €1.8 million.
Leaf Resources has been selected by Unreasonable Impact, a global partnership between Barclays and Unreasonable Group focused on scaling up ventures that have the potential to solve major environmental and societal problems while creating the jobs of tomorrow. Leaf is the only Australian company – as well as the only bioeconomy company – chosen for the current programme, focused on the Asia-Pacific region.
“Cascade use and reuse/-cycling are important factors for the success of the bioeconomy, but the products need to be designed in an appropriate way for recycling. For sure, carbon storage in the material is a positive side effect, but I see this more as a leverage to increase competitiveness of bio-based products compared to fossil-based products, e.g. through a CO2tax for fossil-based products”. To say it – in this interview with Il Bioeconomista – is Andreas Kiesel, a researcher at the University of Hohenheim, who is coordinating the BBI JU Demo Project GRACE, “which is demonstrating the feasibility of 10 bio-based value chains for hemp and miscanthus biomass at an industry relevant scale”.
Interview by Mario Bonaccorso
Bio-on, the Italian company operating in the high quality bioplastic sector, yesterday inaugurated its first owned plant designed to produce 100% natural and biodegradable special PHAs bioplastics for high added value niche markets, such as the microbeads used in the cosmetics sector.
LanzaTech, and its joint venture partner, Shougang Group, a leading Chinese iron and steel producer, announced the successful start-up of the world’s first commercial facility converting industrial emissions to sustainable ethanol. The facility, located at the Jingtang Steel Mill in Caofeidian in Hebei Province, began operations on May 3.
Italian industrial biotech company Bio-on, specialized in the sector of bioplastic of high quality, organic and biodegradable at 100%, set up AMT Labs S.p.A., a newco dedicated to the study, development and production of innovative materials for the tobacco world. Now AMT Labs company, capitalised with 10 million euros, sees the entry of GimaTT, with a 20% share for an investment of 2.2 million euros. GimaTT is a leader in the design and assembly of automatic machines on eletronic basis for the the packaging of products derived from tobacco and, in particular, those of new generation at reduced risk. Gima TT is controlled by IMA S.p.A. and is listed on the Star segment of the Italian Stock Exchange since October 2017.